ArticleFrontiers in pediatrics2025

Pharmacovigilance-based 12-year post-marketing safety analysis of quadrivalent influenza vaccines in children: a VAERS surveillance study.

Honghong Fu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.